相关产品推荐更多 >

重组甲型流感 H1N1 Hemagglutinin/HA蛋白(Y108F, His & AVI Tag)
¥3220
HIV gp120重组蛋白|Recombinant HIV-1 gp120 Protein (group M, subtype CRF07_BC) (His Tag)
¥1010
Influenza A H1N1 (A/California/06/2009) Hemagglutinin / HA Protein (His Tag)
¥4520
Influenza A H7N9 (A/Shanghai/2/2013) Hemagglutinin / HA Protein (His Tag)
¥4520
新冠病毒刺突蛋白
¥4500
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
99
- 英文名:
SARS-CoV-2 (2019-nCoV) Spike RBD(A372T)-His Recombinant Protein
- 保质期:
12个月
- 供应商:
北京义翘神州科技股份有限公司
- 保存条件:
-20℃ to -80℃
- 规格:
100 µg
纯度> 85 % as determined by SDS-PAGE.
内毒素< 1.0 EU per μg protein as determined by the LAL method.
生物活性Testing in progress
蛋白构建A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) Spike RBD(A372T)-His Recombinant Protein (YP_009724390.1) (Arg319-Phe541(A372T)) was expressed with a polyhistidine tag at the C-terminus.
NP No.YP_009724390.1
表达宿主HEK293 Cells
种属2019-nCoV
预测 N 端Arg319
分子量The recombinant SARS-CoV-2 (2019-nCoV) Spike RBD(A372T)-His Recombinant Protein consists of 234 amino acids and predicts a molecular mass of 26.6 kDa.
缓冲液Lyophilized from sterile PBS, pH 7.4.
Please contact us for any concerns or special requirements.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
运输方式In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.
Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
稳定性 & 储存条件Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃
Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
复溶A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验日前,北京大学生命科学学院魏文胜课题组在 Cell 杂志上在线发表题为“Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants”的研究论文。 魏文胜团队首先建立了体外高效制备高纯度环状 RNA 的技术平台,针对新型冠状病毒及其变异株,设计了编码新冠病毒刺突蛋白(Spike)受体结构域(RBD)的环状 RNA 疫苗。 该项研究中制备的针对新冠病毒德尔塔变异株的环状 RNA 疫苗(circRNARBD
新冠肺炎中的NK细胞功能障碍(dysfunction)及策略
管疾病患者。 与SARS一样,COVID-19的免疫病理学产生是基于先天性和细胞介导的免疫反应的失调。SARS-CoV-2也被证明利用ACE2作为细胞进入受体,已有研究表明ACE2在肺部和心血管疾病中的活性均增加。多项研究发现,感染SARS-CoV-2的患者NK和CD8+T细胞数量显著减少,这些细胞表现出功能性衰竭表型,NK抑制性标志物NKG2A和T细胞衰竭标志物PD-1和Tim-3的表达增加。在NK细胞中,抑制性标志物NKG2A的表达导致IFNγ,IL-2和TNFα的表达降低以及颗粒酶B水平降低。与Tim-3在T
5位院士为代表,超12篇CNS大作,5月新冠研究汇总——全方位围攻新冠病毒,值得收藏
的鸡尾酒疗法也引起了大家的关注,不同的抗体可以识别结合域上不同的抗原表位,在未来的临床应用中能够避免免疫逃逸的理想单克隆抗体对。 5 月 8 日,军事医学科学院生物工程研究所陈薇院士团队和西湖大学周强团队强强联合,在预印本平台 bioRxiv 上线题为:A potent neutralizing human antibody reveals the N-terminal domain of the Spike protein of SARS-CoV-2 as a site
技术资料暂无技术资料 索取技术资料




